Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors

By sjmartinez • November 3, 2022

Weitz JI, Szekanecz Z, Charles-Schoeman C, Vranic I, Sahin B, Paciga SA, Wang Z, Hyde C, Martin DA. Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors. RMD Open. 2022 Nov;8(2):e002571. doi: 10.1136/rmdopen-2022-002571. PMID: 36323490.

Tags: Antirheumatic Agents, Arthritis, cardiovascular diseases, Publications, Rheumatoid, Rheumatology

Effectiveness of Mailed Patient Activation Letters for Blood Pressure Control: A Randomized Quality Improvement Trial

Cheng MKW, Eseigbe MO, Orozco JH, Park S, Modrow MF, Fontil V, Pletcher MJ. Effectiveness of Mailed Patient Activation Letters for Blood Pressure Control: A[...]

Correction: Letter to the Editor: An unspoken contributor to VILI in ARDS-asymmetry of lung injury

Barjaktarevic I, Kuhn B. Correction: Letter to the Editor: An unspoken contributor to VILI in ARDS-asymmetry of lung injury. Intensive Care Med. 2025 Nov 4.[...]

Extracellular iron and the lung microbiome in smoking and COPD

Healy C, Campbell C, Hoffman K, Butler JJ, Opron K, Erb-Downward JR, Zhang WZ, Barjaktarevic I, Han MK, Kaner RJ, Curtis JL, Freeman CM, Barr[...]